Advancing Cancer Symptom Control Trials
Author Information
Author(s): Neil MacDonald
Primary Institution: McGill University
Hypothesis
How can we improve the integration of symptom control therapies in cancer treatment?
Conclusion
The study highlights the need for early involvement of patients in symptom control trials to improve outcomes in cancer care.
Supporting Evidence
- Few clinical trials focus on cancer nutrition and symptom control despite their importance.
- Patients often face barriers to participating in symptom control trials due to strict trial criteria.
- Many patients with advanced cancer use untested therapies that are not accounted for in clinical trials.
Takeaway
This study says we should let cancer patients join symptom control trials early, not just when they're very sick, to help them feel better.
Potential Biases
The focus on narrow inclusion criteria in trials may not reflect real-world patient experiences.
Limitations
The study discusses the challenges of trial enrolment and the exclusion of patients from multiple trials.
Participant Demographics
The study mentions that many patients are older and often have comorbid conditions.
Want to read the original?
Access the complete publication on the publisher's website